Modus Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,283
Closed -$218K 145
2025
Q4
$218K Sell
2,283
-1,774
-44% -$174K 0.06% 113
2025
Q3
$396K Hold
4,057
0.11% 97
2025
Q2
$436K Hold
4,057
0.13% 89
2025
Q1
$409K Sell
4,057
-3,716
-48% -$374K 0.13% 90
2024
Q4
$694K Hold
7,773
0.22% 73
2024
Q3
$651K Hold
7,773
0.21% 74
2024
Q2
$599K Hold
7,773
0.21% 73
2024
Q1
$532K Buy
7,773
+941
+14% +$60.5K 0.2% 76
2023
Q4
$395K Hold
6,832
0.16% 83
2023
Q3
$361K Hold
6,832
0.16% 82
2023
Q2
$370K Sell
6,832
-100
-1% -$5.22K 0.16% 81
2023
Q1
$347K Sell
6,932
-125
-2% -$5.89K 0.16% 80
2022
Q4
$327K Hold
7,057
0.16% 83
2022
Q3
$273K Hold
7,057
0.14% 82
2022
Q2
$263K Hold
7,057
0.13% 82
2022
Q1
$313K Hold
7,057
0.14% 82
2021
Q4
$300K Sell
7,057
-492
-7% -$20.7K 0.13% 82
2021
Q3
$328K Hold
7,549
0.14% 82
2021
Q2
$323K Buy
7,549
+471
+7% +$19.8K 0.14% 81
2021
Q1
$274K Hold
7,078
0.13% 86
2020
Q4
$254K Sell
7,078
-326
-4% -$11.8K 0.13% 79
2020
Q3
$283K Sell
7,404
-87
-1% -$3.35K 0.16% 73
2020
Q2
$263K Buy
7,491
+396
+6% +$14.3K 0.17% 72
2020
Q1
$232K Buy
7,095
+2,363
+50% +$92.3K 0.22% 59
2019
Q4
$214K Buy
+4,732
New +$198K 0.17% 66

Other funds holding BSX

Modus Advisors's BSX Position: Q1 2026 in Review

Modus Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,283 shares — an estimated $218K sold.

Modus Advisors first reported a position in BSX in Q4 2019 and held it in 25 quarters. The position peaked at $694K in Q4 2024. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Modus Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Modus Advisors sold 2,283 Boston Scientific shares in Q1 2026, an estimated $218K.
  • Modus Advisors first reported a position in Boston Scientific in Q4 2019 and held it in 25 quarters.
  • Modus Advisors's Boston Scientific position peaked at $694K in Q4 2024.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.